CN Patent

CN111317730A — γ羟基丁酸与单羧酸转运蛋白的施用

Assigned to Jazz Pharmaceuticals Ireland Ltd · Expires 2020-06-23 · 6y expired

What this patent protects

本发明的一种实施方式是提高向患者施用GHB或其盐的安全性和效力。已发现MCT抑制剂，如双氯芬酸、丙戊酸盐、或布洛芬的伴随施用将会影响GHB施用。例如，已发现双氯芬酸降低GHB在体内的效果，从而潜在地导致不安全的情况。而且，已发现丙戊酸盐提高GHB对于机体的效果，从而潜在地导致不安全的情况。

USPTO Abstract

本发明的一种实施方式是提高向患者施用GHB或其盐的安全性和效力。已发现MCT抑制剂，如双氯芬酸、丙戊酸盐、或布洛芬的伴随施用将会影响GHB施用。例如，已发现双氯芬酸降低GHB在体内的效果，从而潜在地导致不安全的情况。而且，已发现丙戊酸盐提高GHB对于机体的效果，从而潜在地导致不安全的情况。

Drugs covered by this patent

Patent Metadata

Patent number: CN111317730A
Jurisdiction: CN
Classification: —
Expires: 2020-06-23
Drug substance claim: No
Drug product claim: No
Assignee: Jazz Pharmaceuticals Ireland Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.